Increased neutrophil oxidative burst metabolism in systemic lupus erythematosus

Lupus

Volumn 21, Issue 14, 2012, Pages 1543-1551

  Perazzio, S F ^a   Salomao R ^a   Silva, N P ^a   Andrade, L E C ^a,b  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b Fleury   (Brazil)

Author keywords

lupus nephritis; neutrophil; oxidative burst; reactive oxygen species; Systemic lupus erythematosus

Indexed keywords

2,7 DICHLOROFLUORESCEIN DIACETATE; ACETOACETIC ACID; ANTIMALARIAL AGENT; AZATHIOPRINE; CYCLOPHOSPHAMIDE; CYCLOSPORIN; DAPSONE; IMMUNOSUPPRESSIVE AGENT; LEFLUNOMIDE; METHOTREXATE; MYCOPHENOLIC ACID; PREDNISONE; REACTIVE OXYGEN METABOLITE; TACROLIMUS; THALIDOMIDE; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BLOOD DONOR; CELL STIMULATION; CLINICAL EVALUATION; CLINICAL FEATURE; CONTROLLED STUDY; DISCOID LUPUS ERYTHEMATOSUS; FEMALE; FLOW CYTOMETRY; HETEROZYGOTE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INNATE IMMUNITY; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; MONOCYTE; NEUTROPHIL; OXIDATION; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; RESPIRATORY BURST; STAPHYLOCOCCUS AUREUS; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADOLESCENT; ADULT; AGED; CASE-CONTROL STUDIES; FLOW CYTOMETRY; FLUORESCEINS; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; NEUTROPHILS; OXIDATION-REDUCTION; PHAGOCYTES; PSEUDOMONAS AERUGINOSA; REACTIVE OXYGEN SPECIES; SEVERITY OF ILLNESS INDEX; STAPHYLOCOCCUS AUREUS; YOUNG ADULT;

EID: 84869461540     PISSN: 09612033     EISSN: 14770962     Source Type: Journal    
DOI: 10.1177/0961203312461060     Document Type: Article

References (37)

1. McCusker C, Warrington R. Primary immunodeficiency. Allergy Asthma Clin Immunol. 2011 ; 10: S11 - S11
2. Gambineri E. New frontiers in primary immunodeficiency disorders: Immunology and beyond. Cell Mol Life Sci. 2012 ; 69: 1-5
3. Etzioni A, Fuleihan R. Primary immunodeficiency: A never-ending story. Curr Opin Allergy Clin Immunol. 2011 ; 11: 503-504
4. Jesus AA, Liphaus BL, Silva CA, et al. Complement and antibody primary immunodeficiency in juvenile systemic lupus erythematosus patients. Lupus. 2011 ; 20: 1275-1284
5. Bussone G, Mouthon L. Autoimmune manifestations in primary immune deficiencies. Autoimmun Rev. 2009 ; 8: 332-336
6. Sleasman JW. The association between immunodeficiency and the development of autoimmune disease. Adv Dent Res. 1996 ; 10: 57-61
7. Galin JI, Malech HL. Update on chronic granulomatous diseases of childhood. J Am Med Assoc. 1990 ; 263: 1533-1537
8. Segal AW, Cross AR, Garcia RC, et al. Absence of cytochrome b245 in chronic granulomatous disease. N Engl J Med. 1983 ; 308: 245-251
9. Carneiro-Sampaio M, Liphaus BL, Jesus AA, et al. Understanding systemic lupus erythematosus physiopathology in the light of primary immunodeficiencies. J Clin Immunol. 2008 ; 28: S34 - S41
10. Winkelstein JA, Marino MC, Johnston RB, et al. Chronic granulomatous disease. Report on a national registry of 368 patients. Medicine (Baltimore). 2000 ; 79: 155-169
11. Humbert JR, Fishman CB, Weston WL, DeArmey PA, Thoren CH. Frequency of the carrier state for X-linked chronic granulomatous disease among females with lupus erythematosus. Clin Genet. 1976 ; 10: 16-20
12. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1997 ; 40: 1725-1725
13. Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH. Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum. 1992 ; 35: 630-640
14. Gladman D, Glinzler E, Goldsmith C, et al. The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for systemic lupus erythematosus. Arthritis Rheum. 1996 ; 39: 363-378
15. Conley ME, Notarangelo LD, Etzioni A. Diagnostic criteria for primary immunodeficiencies. Clin Immunol. 1999 ; 93: 190-197
16. Notarangelo LD, Fischer A, Geha RS, et al. International Union of Immunological Societies Expert Committee on Primary Immunodeficiencies. Primary immunodeficiencies: 2009 update. J Allergy Clin Immunol. 2009 ; 124: 1161-1178
17. Böhmer RH, Trinkle LS, Staneck JL. Dose effects of LPS on neutrophils in a whole blood flow cytometric assay of phagocytosis and oxidative burst. Cytometry. 1992 ; 13: 525-531
18. Bass DA, Parce JW, Dechatelet LR, Szejda P, Seeds MC, Thomas M. Flow cytometric studies of oxidative product formation by neutrophils: A graded response to membrane stimulation. J Immunol. 1983 ; 130: 1910-1917
19. Martins PS, Kallas EG, Neto MC, Dalboni MA, Blecher S, Salomão R. Upregulation of reactive oxygen species generation and phagocytosis, and increased apoptosis in human neutrophils during severe sepsis and septic shock. Shock. 2003 ; 20: 208-212
20. Sutton S. Measurement of microbial cells by optical density. J Val Technol. 2011 ; 17: 46-49
21. Orme J, Mohan C. Macrophages and neutrophils in SLE-An online molecular catalog. Autoimmun Rev. 2012 ; 11: 365-372
22. Alves CM, Marzocchi-Machado CM, Louzada-Junior P, et al. Superoxide anion production by neutrophils is associated with prevalent clinical manifestations in systemic lupus erythematosus. Clin Rheumatol. 2008 ; 27: 701-708
23. Niwa Y, Sakane T, Fukuda Y, Miyachi Y, Kanoh T. Modulation of the immunoreactivity of a T-lymphocyte subpopulation by neutrophil-released prostaglandin. J Clin Lab Immunol. 1985 ; 17: 37-44
24. Shingu M, Oribe M, Todoroki T, et al. Serum factors from patients with systemic lupus erythematosus enhancing superoxide generation by normal neutrophils. J Invest Dermatol. 1983 ; 81: 212-215
25. Casellas AM, Prat A, Llera A, Manni J, Boveris A, Sarano JF. Increased superoxide production by polymorphonuclear leukocytes in systemic lupus erythematosus. Clin Exp Rheumatol. 1991 ; 9: 511-515
26. Hashimoto Y, Ziff M, Hurd ER. Increased endothelial cell adherence, aggregation, and superoxide generation by neutrophils incubated in systemic lupus erythematosus and Felty's syndrome sera. Arthritis Rheum. 1982 ; 25: 1409-1418
27. Rhee MS, Rynes RI, Pickering RJ, et al. Enhancement of granulocyte oxidative metabolism in sera from patients with C2 deficiency and systemic lupus erythematosus. Int Arch Allergy Appl Immunol. 1983 ; 72: 46-52
28. Marzocchi-Machado CM, Alves CM, Azzolini AE, Polizello AC, Carvalho IF, Lucisano-Valim YM. Fcg and complement receptors: expression, role and co-operation in mediating the oxidative burst and degranulation of neutrophils of Brazilian systemic lupus erythematosus patients. Lupus. 2002 ; 11: 240-248
29. Moroni G, Novembrino C, Quaglini S, et al. Oxidative stress and homocysteine metabolism in patients with lupus nephritis. Lupus. 2010 ; 19: 65-72
30. Hurst J, von Landenberg P. Toll-like receptors and autoimmunity. Autoimmun Rev. 2008 ; 7: 204-208
31. Leadbetter EA, Rifkin IR, Hohlbaum AM, Beaudette BC, Shlomchik MJ, Marshak-Rothstein A. Chromatin-IgG complexes activate B-cells by dual engagement of IgM and Toll-like receptors. Nature. 2002 ; 416: 603-607
32. Alam K, Moinuddin-Jabeen S. Immunogenicity of mitochondrial DNA modified by hydroxyl radical. Cell Immunol. 2007 ; 247: 12-7
33. Al Arfaj AS, Chowdhary AR, Khalil N, Ali R. Immunogenicity of singlet oxygen modified human DNA: implications for anti-DNA antibodies in systemic lupus erythematosus. Clin Immunol. 2007 ; 124: 83-89
34. Kurien BT, Hensley K, Bachmann M, Scofield RH. Oxidatively modified autoantigens in autoimmune diseases. Free Radic Biol Med. 2006 ; 41: 549-556
35. Sheikh Z, Ahmad R, Sheikh N, Ali R. Enhanced recognition of reactive oxygen species damaged human serum albumin by circulating systemic lupus erythematosus autoantibodies. Autoimmunity. 2007 ; 40: 512-520
36. Fernandez D, Bonilla E, Phillips P, Perl A. Signaling abnormalities in systemic lupus erythematosus as potential drug targets. Endocr Metab Immune Disord Drug Tragets. 2006 ; 6: 305-311
37. Garcia-Romo GS, Caielli S, Vega B, et al. Netting neutrophils are major inducers of type I IFN production in pediatric systemic lupus erythematosus. Sci Transl Med 2011 9; 3: 73ra20.